|
Post by Lyme Challenged on Sept 4, 2016 3:02:51 GMT -5
I am proud to be part of an amazing team of scientists from the National Cancer Institute, Department of Defense, Veterans Administration, and academia who are designing a cutting-edge proteogenomics clinical trial to improve the delivery of precision-based oncology care to cancer patients. This study is an integral part of Vice President Biden's Cancer Moonshot Program to accelerate the pace of breakthroughs in cancer research and clinical care. For my friends in the Lyme disease (and associated diseases) community, we are working towards delivering precision medicine to folks suffering with chronic infections. Our goal is to "cure" Lyme and co-infections through novel targeted approaches, rather than suppressing the infections and waiting for resistance to develop.
|
|